No Data Yet
AtriCure has successfully performed the first-in-human procedures using its novel dual-energy cardiac ablation platform, which combines Pulsed Field Ablation (PFA) and Radiofrequency Ablation (RFA). The technology demonstrated a sub-60-second ablation time, signaling a significant step in competing within the rapidly growing PFA market.